![John McAdory](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John McAdory
Operationeel Directeur bij
ONCOLYTICS BIOTECH INC.
Vermogen: - $ op 31-07-2026
Profiel
John McAdory is Chief Operating Officer at Oncolytics Biotech, Inc. since 2026.
Formerly, Mr. McAdory was Vice President-Clinical Operations at CG Oncology, Inc. from 2020 to 2026.
Education includes undergraduate studies at Hampton University and graduate studies at The University of North Carolina at Chapel Hill.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-06-2026 | 0 ( -.--% ) | - $ | 31-07-2026 |
Actieve functies van John McAdory
| Bedrijven | Functie | Begin |
|---|---|---|
| ONCOLYTICS BIOTECH INC. | Operationeel Directeur | 14-01-2026 |
Eerdere bekende functies van John McAdory
| Bedrijven | Functie | Einde |
|---|---|---|
| CG ONCOLOGY, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2026 |
Opleiding van John McAdory
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
32
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Oncolytics Biotech, Inc.
 Oncolytics Biotech, Inc. BiotechnologyHealth Technology Discovers and develops pharmaceutical products for the treatment of cancers | Health Technology |
Hampton University
 Hampton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of North Carolina at Chapel Hill
 The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CG Oncology, Inc.
 CG Oncology, Inc. BiotechnologyHealth Technology Operates as a late-stage clinical biopharmaceutical company focused on developing and commercializing backbone bladder-sparing therapeutic | Health Technology |
